TGFB1 and systemic lupus erythematosus: We had previously shown that nanoparticle (NP)-mediated delivery of IL-2 and TGF-β (two cytokines that are deficient in SLE) to mouse CD2+ and CD4+ cells induced tolerogenic immune responses that protected mice from a lupus-like syndrome (6, 7).